Chester County News and Community Website
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has shared its latest business updates and unaudited financial results for the third quarter ending September 30, 2024. The company is advancing …
Traws Pharma Reports Q3 Financials and Updates on Clinical Advances Read More
WILMINGTON, DE — Thunder Power Holdings, Inc. (Nasdaq: AIEV) has released its unaudited financial results for the third quarter of 2024, revealing a period with no revenue, consistent with the …
Thunder Power Holdings Reports Q3 2024 Results and Strategic Vision for EV Market Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced its financial results for the third quarter of 2024, alongside significant progress in its lead program for firmonertinib, a …
ArriVent BioPharma Reports Advancements and Q3 2024 Financial Results Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has released its financial results for the third quarter of 2024, alongside updates on its clinical trial programs. A key highlight includes …
Cabaletta Bio Reports Q3 2024 Financial Results and Clinical Trial Advancements Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has reported a remarkable third quarter in 2024, achieving a record revenue of $2.94 million. This represents a 141% increase from the same …
NEXGEL Achieves Record Revenue in Q3 2024 with Promising Growth Outlook Read More
HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) has released its financial results for the third quarter of 2024, reporting a revenue of $8.8 million, slightly down from $8.9 …
STRATA Skin Sciences Reports Q3 2024 Financial Results and Corporate Progress Read More
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) this week reported its third quarter financial results for 2024, highlighting substantial progress in its PBFT02 gene therapy program for frontotemporal dementia …
Passage Bio Advances PBFT02 Gene Therapy Program Amidst Positive Q3 2024 Results Read MoreNEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) this week announced its third quarter financial results for 2024, alongside significant updates on its clinical programs. The company is …
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has reported its financial and operational results for the third quarter of 2024, amid significant developments including the approval of its acquisition of …
Neuronetics Announces Q3 2024 Financial Results and Greenbrook TMS Acquisition Approval Read More
YARDLEY, PA — Optinose (NASDAQ: OPTN) has released its financial results for the third quarter of 2024, revealing an increase in net revenue from its flagship product, XHANCE, and adjustments …
Optinose Reports Q3 2024 Financial Results, Highlights XHANCE Performance Read More